Tenet Healthcare Stock-Based Compensation Growth & History (THC)

Tenet Healthcare's stock-based compensation was $104.0M for fiscal 2025.

View full Tenet Healthcare company overview

Tenet Healthcare annual stock-based compensation history

Tenet Healthcare annual stock-based compensation

Fiscal yearPeriod endedStock-based compensationChangeGrowth
20252025-12-31$104.0M$37.0M+55.22%
20242024-12-31$67.0M$1.0M+1.52%
20232023-12-31$66.0M$10.0M+17.86%
20222022-12-31$56.0M$00.00%
20212021-12-31$56.0M$12.0M+27.27%
20202020-12-31$44.0M$2.0M+4.76%
20192019-12-31$42.0M−$4.0M−8.70%
20182018-12-31$46.0M−$13.0M−22.03%
20172017-12-31$59.0M−$9.0M−13.24%
20162016-12-31$68.0M−$1.0M−1.45%
20152015-12-31$69.0M$18.0M+35.29%
20142014-12-31$51.0M$15.0M+41.67%
20132013-12-31$36.0M$4.0M+12.50%
20122012-12-31$32.0M$8.0M+33.33%
20112011-12-31$24.0M$2.0M+9.09%
20102010-12-31$22.0M−$1.0M−4.35%
20092009-12-31$23.0M−$10.0M−30.30%
20082008-12-31$33.0M

Tenet Healthcare stock-based compensation trends

Over the last five fiscal years, Tenet Healthcare's stock-based compensation increased from $44.0M to $104.0M, a change of $60.0M. The latest reported quarter, Q2 2026, shows $44.0M.

About the metric

What stock-based compensation means

Stock-based compensation is the expense associated with equity awards such as restricted stock and employee options. It is a non-cash expense when recognized, but it can dilute existing shareholders unless offset by share repurchases.

Calculation and source

SEC-reported stock-based compensation

TickerStat standardizes share-based compensation reported in company SEC filings. The history shows recognized compensation expense or its cash-flow-statement adjustment, not the grant-date value of new awards or a forecast of future dilution. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Tenet Healthcare source filings ↗

Community posts

It’s quiet here.

No posts about THC yet. Start the conversation.

Write the first post